Skip to main content
. Author manuscript; available in PMC: 2021 Mar 29.
Published in final edited form as: J Pathol. 2020 Sep 26;252(4):371–383. doi: 10.1002/path.5531

Figure 6.

Figure 6.

CRAMP peptide administration attenuates alcohol-induced IL-1β production via inhibiting inflammasome activation signaling. (A) Serum IL-1β levels. (B) Serum LPS levels. (C) Hepatic mRNA expression of Lbp and Cd14. (D) Serum UA levels. (E) Serum XO activity. (F) Proposed scheme for the effects of CRAMP on ALD. Data are expressed as mean SEM (n = 4–8).